Project Glasswing

6 items

blog.himanshuanand.com 2026-05-11-3

The 90 Day Disclosure Policy Is Dead

Coordinated disclosure was an information-containment regime, and containment fails when discovery diffuses. Eleven independent researchers landed the same critical bug in six weeks; Copy Fail took roughly an hour of AI-assisted scanning to find; Dirty Frag's embargo collapsed within hours via unrelated rediscovery, with Microsoft Defender confirming in-the-wild exploitation a day later. The offense side has integrated LLMs into exploit pipelines. The defense and policy layer largely has not, and that asymmetry is the actual risk — CVE feeds are now lagging artifacts, and patch-diff intelligence is the signal that matters.

Anthropic Blog 2026-04-16-2

Introducing Claude Opus 4.7

Anthropic held headline rates at $5/$25 per million tokens while shipping a tokenizer that inflates inputs by up to 35%, which makes price-per-token comparisons meaningless. The capability jump is real: CursorBench up 12 points, Notion tool errors cut by two-thirds, XBOW vision nearly doubled. The only number that matters now is price-per-useful-output, and that requires workload-specific benchmarking most teams won't run.

tanyaverma.sh 2026-04-13-1

The Closing of the Frontier

Two-thirds of MATS symposium research posters ran on Chinese open-source models because Anthropic's Mythos restrictions closed off Western frontier access to independent safety researchers. The safety case for restricted access is degrading the safety research pipeline it claims to protect. The policy question isn't content moderation: it's whether frontier model access needs due process obligations the way utilities do.

UK AI Security Institute 2026-04-13-3

AISI Evaluation of Claude Mythos Preview's Cyber Capabilities

A UK government lab confirmed Mythos can autonomously execute a 32-step corporate network attack end-to-end, outperforming every tested model including GPT-5, with performance still scaling at the 100M token ceiling. The evaluation tested capability against undefended ranges, so what AISI validated is threat potential, not operational impact against a real defended environment. The structural shift is that government evaluation infrastructure is becoming the third-party verification layer for frontier AI claims, sitting between self-reported lab benchmarks and the market the way FDA trials sit between pharma and prescribers.

Barron's · 2026-04-08 2026-04-10-w3

How Anthropic Ended the Cybersecurity Stock Selloff

CRWD fell 7% and PANW 6% the day autonomous vulnerability discovery at scale became visible; twelve days later both reversed, CRWD +5% and PANW +4%, after Anthropic named them Glasswing launch partners with exclusive Mythos access. The same capability that read as replacement became amplifier the moment it was sold as one — which is the clearest demonstration this week of how scarcity and safety become indistinguishable as business strategy. At $25/$125 per million tokens and $100M in credits deployed as customer acquisition, Anthropic is using restricted frontier access the way platform companies use exclusivity deals: not to limit adoption, but to route it. This is the Glasswing inversion of the OpenClaw decision — one story about cutting access to protect margins, the other about granting access to establish a coalition, both moves made in the same week by the same company. The $30B ARR disclosure in the same window wasn't incidental; restricted access compounds fastest when the numbers confirm the frontier is real.

Barron's 2026-04-08-2

How Anthropic Ended the Cybersecurity Stock Selloff

CRWD dropped 7% and PANW 6% the day the Mythos leak surfaced autonomous vulnerability discovery at scale. Twelve days later both reversed, CRWD +5% and PANW +4%, when Anthropic named them Glasswing launch partners with exclusive model access: the same capability that looked like a replacement became an amplifier the moment it was sold as one. At $25/$125 per million tokens, $100M in credits as customer acquisition, and $30B ARR disclosed the same week, restricted frontier access isn't just safety policy; it's the go-to-market.